104 related articles for article (PubMed ID: 1112170)
1. Pimozide in chronic schizophrenic outpatients.
Clark ML; Huber WK; Hill D; Wood F; Costiloe JP
Dis Nerv Syst; 1975 Mar; 36(3):137-41. PubMed ID: 1112170
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
3. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
Donlon PT; Swaback DO; Osborne ML
Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
[TBL] [Abstract][Full Text] [Related]
4. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
Kolivakis T; Azim H; Kingstone E
Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
[No Abstract] [Full Text] [Related]
6. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
Claghorn JL
Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
[No Abstract] [Full Text] [Related]
7. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study.
Haas S; Beckmann H
Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of pimozide.
Anumonye A; Onibuwe-Johnson T; Marinho AA
West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and statistical evaluation of neuroleptic pimozide].
Glatzel J
Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
[No Abstract] [Full Text] [Related]
10. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
Engelhardt DM; Rudorfer L; Rosen B
J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
Kudo Y
Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
[No Abstract] [Full Text] [Related]
13. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
Abuzzahab FS
Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
[No Abstract] [Full Text] [Related]
14. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
Amin MM; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
[No Abstract] [Full Text] [Related]
15. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
Vergara L; Amin MM; Ban TA
Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
[No Abstract] [Full Text] [Related]
16. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
17. [Dose-effect relations. Doubleblind study on two different doses of pimozide (author's transl)].
Fleischhauer J
Arzneimittelforschung; 1978; 28(9):1491-2. PubMed ID: 582541
[TBL] [Abstract][Full Text] [Related]
18. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
Nakra BR; Wickramasinghe NA
Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
[TBL] [Abstract][Full Text] [Related]
19. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
Abuzzahab FS; Zimmermann RL
Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
[No Abstract] [Full Text] [Related]
20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
